|
GlaxoSmithKline Pharmaceuticals Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
44059.12 Cr.
|
P/BV
|
22.58
|
Book Value (Rs.)
|
115.19
|
|
52 Week High/Low (Rs.)
|
3516/1921
|
FV/ML
|
10/1
|
P/E(X)
|
47.36
|
|
Bookclosure
|
30/05/2025
|
EPS (Rs.)
|
54.91
|
Div Yield (%)
|
2.08
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 54.52 | 41.14 | 36.08 | 99.29 | 31.35 |
| Diluted EPS (Rs.) | 54.76 | 34.83 | 36.05 | 100.04 | 21.14 |
| Cash EPS (Rs.) | 58.70 | 38.94 | 39.93 | 104.06 | 25.78 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 115.19 | 104.93 | 102.79 | 157.19 | 87.26 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 115.19 | 104.93 | 102.79 | 157.19 | 87.26 |
| Revenue From Operations / Share (Rs.) | 221.32 | 203.87 | 191.95 | 193.50 | 172.70 |
| PBDIT / Share (Rs.) | 78.11 | 60.88 | 53.42 | 49.45 | 41.84 |
| PBIT / Share (Rs.) | 74.17 | 56.76 | 49.54 | 45.42 | 37.20 |
| PBT / Share (Rs.) | 74.37 | 48.18 | 49.37 | 45.99 | 26.80 |
| Net Profit / Share (Rs.) | 54.76 | 34.83 | 36.05 | 100.04 | 21.14 |
| NP After MI And SOA / Share (Rs.) | 54.91 | 35.07 | 36.41 | 100.04 | 21.14 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 35.29 | 29.86 | 27.82 | 25.55 | 24.22 |
| PBIT Margin (%) | 33.51 | 27.84 | 25.80 | 23.47 | 21.53 |
| PBT Margin (%) | 33.60 | 23.63 | 25.72 | 23.76 | 15.51 |
| Net Profit Margin (%) | 24.74 | 17.08 | 18.78 | 51.69 | 12.24 |
| NP After MI And SOA Margin (%) | 24.81 | 17.20 | 18.96 | 51.69 | 12.24 |
| Return on Networth / Equity (%) | 47.67 | 33.42 | 35.41 | 63.64 | 24.22 |
| Return on Capital Employeed (%) | 57.03 | 47.33 | 41.95 | 26.21 | 35.80 |
| Return On Assets (%) | 22.64 | 16.70 | 18.53 | 36.57 | 11.49 |
| Asset Turnover Ratio (%) | 0.97 | 1.00 | 0.80 | 0.83 | 0.93 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 1.79 | 1.84 | 1.88 | 2.18 | 1.63 |
| Quick Ratio (X) | 1.54 | 1.49 | 1.53 | 1.87 | 1.22 |
| Inventory Turnover Ratio (X) | 7.45 | 1.11 | 0.81 | 1.04 | 0.89 |
| Dividend Payout Ratio (NP) (%) | 80.12 | 91.24 | 247.21 | 29.98 | 189.20 |
| Dividend Payout Ratio (CP) (%) | 74.76 | 81.66 | 223.39 | 28.82 | 155.15 |
| Earning Retention Ratio (%) | 19.88 | 8.76 | -147.21 | 70.02 | -89.20 |
| Cash Earning Retention Ratio (%) | 25.24 | 18.34 | -123.39 | 71.18 | -55.15 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 1007.30 | 573.35 | 499.36 | 419.65 | 200.69 |
| Interest Coverage Ratio (Post Tax) (%) | 703.51 | 408.84 | 336.84 | 185.96 | 131.22 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 47339.67 | 31854.06 | 21275.97 | 25686.86 | 23243.30 |
| EV / Net Operating Revenue (X) | 12.63 | 9.22 | 6.54 | 7.84 | 7.94 |
| EV / EBITDA (X) | 35.77 | 30.89 | 23.51 | 30.67 | 32.80 |
| MarketCap / Net Operating Revenue (X) | 13.00 | 9.53 | 6.90 | 8.59 | 8.34 |
| Retention Ratios (%) | 19.87 | 8.75 | -147.21 | 70.01 | -89.20 |
| Price / BV (X) | 24.98 | 18.52 | 12.88 | 10.58 | 16.51 |
| Price / Net Operating Revenue (X) | 13.00 | 9.53 | 6.90 | 8.59 | 8.34 |
| EarningsYield | 0.01 | 0.01 | 0.02 | 0.06 | 0.01 |
